These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 14710591)
1. Low-dose (2.5 mg/day) finasteride treatment in hirsutism. Bayram F; Müderris I; Güven M; Ozçelik B; Keleştimur F Gynecol Endocrinol; 2003 Oct; 17(5):419-22. PubMed ID: 14710591 [TBL] [Abstract][Full Text] [Related]
2. Comparison of high-dose finasteride (5 mg/day) versus low-dose finasteride (2.5 mg/day) in the treatment of hirsutism. Bayram F; Müderris II; Güven M; Keleştimur F Eur J Endocrinol; 2002 Oct; 147(4):467-71. PubMed ID: 12370107 [TBL] [Abstract][Full Text] [Related]
3. Finasteride treatment for one year in 35 hirsute patients. Bayram F; Müderris II; Sahin Y; Keleştimur F Exp Clin Endocrinol Diabetes; 1999; 107(3):195-7. PubMed ID: 10376445 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism. Sahin Y; Dilber S; Keleştimur F Fertil Steril; 2001 Mar; 75(3):496-500. PubMed ID: 11239530 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism. Bayhan G; Bahçeci M; Demirkol T; Ertem M; Yalinkaya A; Erden AC Clin Exp Obstet Gynecol; 2000; 27(3-4):203-6. PubMed ID: 11214952 [TBL] [Abstract][Full Text] [Related]
6. The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism. Lakryc EM; Motta EL; Soares JM; Haidar MA; de Lima GR; Baracat EC Gynecol Endocrinol; 2003 Feb; 17(1):57-63. PubMed ID: 12724020 [TBL] [Abstract][Full Text] [Related]
7. Clinical and endocrine effects of finasteride, a 5 alpha-reductase inhibitor, in women with idiopathic hirsutism. Ciotta L; Cianci A; Calogero AE; Palumbo MA; Marletta E; Sciuto A; Palumbo G Fertil Steril; 1995 Aug; 64(2):299-306. PubMed ID: 7615107 [TBL] [Abstract][Full Text] [Related]
8. Comparison of cyproterone acetate plus ethinyl estradiol and finasteride in the treatment of hirsutism. Sahin Y; Bayram F; Keleştimur F; Müderris I J Endocrinol Invest; 1998 Jun; 21(6):348-52. PubMed ID: 9699125 [TBL] [Abstract][Full Text] [Related]
9. Intermittent low-dose finasteride is as effective as daily administration for the treatment of hirsute women. Tartagni M; Schonauer MM; Cicinelli E; Petruzzelli F; De Pergola G; De Salvia MA; Loverro G Fertil Steril; 2004 Sep; 82(3):752-5. PubMed ID: 15374729 [TBL] [Abstract][Full Text] [Related]
10. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771 [TBL] [Abstract][Full Text] [Related]
11. Intermittent low-dose finasteride administration is effective for treatment of hirsutism in adolescent girls: a pilot study. Tartagni MV; Alrasheed H; Damiani GR; Montagnani M; De Salvia MA; De Pergola G; Tartagni M; Loverro G J Pediatr Adolesc Gynecol; 2014 Jun; 27(3):161-5. PubMed ID: 24559619 [TBL] [Abstract][Full Text] [Related]
12. Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up. Castello R; Tosi F; Perrone F; Negri C; Muggeo M; Moghetti P Fertil Steril; 1996 Nov; 66(5):734-40. PubMed ID: 8893676 [TBL] [Abstract][Full Text] [Related]
13. A comparison between spironolactone and spironolactone plus finasteride in the treatment of hirsutism. Keleştimur F; Everest H; Unlühizarci K; Bayram F; Sahin Y Eur J Endocrinol; 2004 Mar; 150(3):351-4. PubMed ID: 15012621 [TBL] [Abstract][Full Text] [Related]
14. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women. Fruzzetti F; de Lorenzo D; Parrini D; Ricci C J Clin Endocrinol Metab; 1994 Sep; 79(3):831-5. PubMed ID: 8077369 [TBL] [Abstract][Full Text] [Related]
15. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary syndrome. Falsetti L; De Fusco D; Eleftheriou G; Rosina B Gynecol Endocrinol; 1997 Aug; 11(4):251-7. PubMed ID: 9272421 [TBL] [Abstract][Full Text] [Related]
16. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism. Müderris II; Bayram F; Sahin Y; Keleştimur F; Tutuş A; Ayata D Fertil Steril; 1996 Aug; 66(2):220-2. PubMed ID: 8690105 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of a 12-month treatment with finasteride in idiophathic and polycystic ovary syndrome-associated hirsutism. Petrone A; Civitillo RM; Galante L; Giannotti F; D'Antò V; Rippa G; Tolino A Clin Exp Obstet Gynecol; 1999; 26(3-4):213-6. PubMed ID: 10668160 [TBL] [Abstract][Full Text] [Related]
18. Effect of finasteride in idiopathic hirsutism. Faloia E; Filipponi S; Mancini V; Di Marco S; Mantero F J Endocrinol Invest; 1998 Nov; 21(10):694-8. PubMed ID: 9854686 [TBL] [Abstract][Full Text] [Related]
19. A prospective randomized trial comparing finasteride to spironolactone in the treatment of hirsute women. Wong IL; Morris RS; Chang L; Spahn MA; Stanczyk FZ; Lobo RA J Clin Endocrinol Metab; 1995 Jan; 80(1):233-8. PubMed ID: 7829618 [TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized trial comparing flutamide (250 mg/d) and finasteride (5 mg/d) in the treatment of hirsutism. Müderris II; Bayram F; Güven M Fertil Steril; 2000 May; 73(5):984-7. PubMed ID: 10785225 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]